Basis of Allotment

PIethico

PIethico

Pledged to ethics

PLETHICO PHARMACEUTICALS LIMITED

(The Company was incorporated on 4"' December 1991 as Plethico Pharmaceuticals Private Limited under the Companies Act, 1956.In 1992, our Company was converted to a public limited company and received a fresh certificate of incorporation on 27" August 1992. For details of incorporation and change in name, please refer to the chapter on Our History and Corporate Structure at Page 120).
Registered Office: A.B.Road, Manglia-453 771, Indore (M.P.), India. Tel: +91-0731-2422881-85;
Fax: +91-0731-2420938;
Corporate Office: Plethico Pharmaceuticals Limited, 1st Floor, Crimpage Corporation, Plot No. 57, Street No.17, M.I.D.C, Andheri (E) Mumbai-400093.
Tel: +91-022-56988301; Fax: +91-022-56988330. Compliance Officer: Mr. Pankaj Pabaiya;
E-mail: ipo@plethico.com; Website: www.plethico.com

BASIS OF ALLOTMENT

PUBLIC ISSUE OF 36,66,667 EQUITY SHARES OF RS. 10 EACH FOR CASH AT A PRICE OF RS. 300 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 290 PER EQUITY SHARE) AGGREGATING RS. 1100 MILLION, (the "ISSUE"), BY PLETHICO PHARMACEUTICALS LIMITED ("PLETHICO", the "COMPANY" or "tile ISSUER"). THE ISSUE WILL CONSTITUTE 10.76 % OF THE FULLY DILUTED POST-ISSUE PAID-UP CAPITAL OF OUR COMPANY

ISSUE PRICE Rs. 300 PER EQUITY SHARE OF FACE VALUE Rs.10. THE FACE VALUE OF THE SHARES IS Rs. 10 AND THE ISSUE PRICE IS 30 TIMES OF THE FACE VALUE.
In terns of Rule 19(2)(b) of the SCRR, this being an offer for less than 25% of the post Issue Capital, the Issue was made through the 100% Book Building Process wherein atleast 60% of the Issue to the public was allocated on a proportionate basis to Qualified Institutional Buyers, out of which 5% of the QIB Portion was made available for allocation on a proportionate basis to Mutual Funds only, and the remaining QIB Portion was available for allocation on a proportionate basis to all Qualified Institutional Buyers, including Mutual Funds. Further, not less than 10% of the Issue to the public was available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 30% of the Issue to the public was available for allocation on a proportionate basis to Retail Individual Bidders, subject to valid Bids being received at or above the Issue Price.

The Issue received 1,46,586 applications for 9,28,18,560 Equity Shares resulting in 25.3142 times subscription. The details of the applications received in the Issue from Retail Bidders / Investors, Non-Institutional Bidders / Investors and Qualified Institutional Buyers' categories (before technical rejections) are as under:

Category No. of Applications No. of Equity Shares Applied For Subscription (*)
Retail Investors 1,46,179 2,13,69,920 19.4272
Non-Institutional Investors 350 1,57,65,420 42.9966
Qualified Institutional Buyers 57 5,56,83,220 25.3106
Total 1,46,586 9,28,18,560 25.3142

(*): Note: Number of times of the respective category.

Final Demand
A sample of the final demand at different bid prices is as under:

Bid Price
(Rs./ Share)
No. of Equity Shares % to Total Bids Cumulative Total Bids Cumulative % to Total Bids
280 2424820 2.4507 98943760 100.0000
281 60 0.0001 96518940 97.5493
282 9880 0.0100 96518880 97.5492
283 140 0.0001 96509000 97.5392
284 420 0.0004 96508860 97.5391
285 47660 0.0482 96508440 97.5387
287 680 0.0007 96460780 97.4905
288 180 0.0002 96460100 97.4898
290 2425260 2.4512 96459920 97.4896
291 3440 0.0035 94034660 95.0385
292 400 0.0004 94031220 95.0350
294 35380 0.0358 94030820 95.0346
295 136180 0.1376 93995440 94.9989
297 200 0.0002 93859260 94.8612
298 160 0.0002 93859060 94.8610
299 260 0.0003 93656900 94.8609
300 73991160 74.7810 93858640 94.8606
Cut-off 19867480 20.0796 19867480 20.0796
98943760 100.0000

The Basis of Allotment was finalized in consultation with Bombay Stock Exchange Limited ('BSE') on Friday, April 28, 2005.
A. Allotment to Retail Investors
The Basis of Allotment to the Retail Investors, who have bid at cut-off or at the Issue Price of Rs. 300/- per Equity Share, was finalized in consultation with BSE. The category was over subscribed 19.01795 times. The total number of Equity Shares allotted in this category is 11,00,000. The category-wise details of the Basis of Allotment are as under: t'

Category No. of
Applications
% to total Total No.of Equity
Shares Applied
% to total No. of Equity
Shares Allotted
Ratio Total No. of Equity
Shares Allotted
20 15864 11.04 317280 1.52 20 01:19 16700
40 13761 9.58 550440 2.63 20 02:19 28980
60 10037 6.99 602220 2.88 20 03:19 31700
80 6871 4.78 549680 2.63 20 04:19 28940
100 12643 8.8 1264300 6.04 20 05:19 66540
120 4063 2.83 487560 2.33 20 06:19 25660
140 3786 2.64 530040 2.53 20 07:19 27900
160 46441 32.33 7430560 35.52 20 08:19 391060
180 1127 0.78 202860 0.97 20 09:19 10680
200 1630 1.13 326000 1.56 20 10:19 17160
220 311 0.22 68420 0.33 20 11:19 3600
240 552 0.38 132480 0.63 20 12:19 6980
260 238 0.17 61880 0.3 20 13:19 3260
280 268 0.19 75040 0.36 20 14:19 3940
300 1071 0.75 321300 1.54 20 15:19 16920
320 24999 17.4 7999680 38.24 20 21:25 419980

B. Allotment to Non-Institutional Investors
The Basis of Allotment to the Non-institutional Investors, who have bid at the issue Price of Rs. 300/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 42.95665 times. The total number of Equity Shares allotted in this category is 3,66,667. The category-wise details of the Basis of Allotment are as under:

Category No. of
Applications
% to total Total No.of Equity
Shares Applied
% to total No. of Equity
Shares Allotted
Ratio Total No. of Equity
Shares Allotted
33340 7 2.05 233380 1.48 776 FIRM 5432
66660 4 1.17 266640 1.69 1552 FIRM 6208
100000 4 1.17 400000 2.54 2328 FIRM 9312
166660 1 0.29 166660 1.06 3880 FIRM 3880
174600 1 0.29 174600 1.11 4064 FIRM 4064
214000 1 0.29 214000 1.36 4982 FIRM 4982
250000 1 0.29 250000 1.59 5820 FIRM 5820
333300 1 0.29 333300 2.12 7759 FIRM 7759
633320 1 0.29 633320 4.02 14743 FIRM 14743
666660 1 0.29 666660 4.23 15519 FIRM 15519
2500000 1 0.29 2500000 15.87 58191 FIRM 58191
3400000 1 0.29 3400000 21.59 79134 FIRM 79134
3666660 1 0.29 3666860 23.28 85340 FIRM 85340

C. Allotment to QIBs

The total number of Equity Shares allotted 01 Bs is22,00,000 Equity Shares as follows:

Category FIs/Banks MFs FIIs Insurance Companies Venture Capitals Total
No. of Shares 1,91,174 4,93,515 14,32,573 82,738   - 22,00,000

Pursuant to Clause 6.8.3.2 (g) of the SEBI (Disclosure and Investor Protection Guidelines), 2000 and item no. 19 of the Notes to the Capital Structure (page no. 25) of the Prospectus dated April 19, 2006 the Company has rounded-off fractional Equity Shares to the nearest multiple of one (1) Equity Share.

The Committee of Directors for Initial Public Offering ('IPO') of the Company at it's Meeting held at lndore on April 29, 2006 has approved the basis of allocation of shares and allotted the shares to various successful applicants.

The Refund Orders will be dispatched to the address of the investors as registered with the depositories in case the same is not received within ten (10) days, investors may contact at the address given below. The Refund Orders have been over-printed with the Bank Mandate details as registered, if any, with the depositories. The Equity Shares allotted to successful applicants are being credited to their respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on Bombay Stock Exchange Limited and National Stock Exchange of India Limited within seven (7) working days from the date of approval of the Basis of Allotment.

INVESTORS MAY PLEASE NOTE
These details of allotment made, would be hosted on the website of the Registrar to the Issue, Intime Spectrum Registry Limited at www.intimespectrum.com
All future correspondence in this regard may kindly be addressed to the Registrar to the Issue, Intime Spectrum Registry limited, quoting full name of the First/ Sole Applicant, Serial Number of the Bid-cum-Application Form, Number of Equity Shares bid for, Name of the Member of the Syndicate, Place where the bid was submitted and payment details at the address given below:

Intime Spectrum Registry Limited
Unit: Plethico Pharmaceuticals Limited
C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (West), Mumbai -400 078 TelephoneNo.:+91-22-25960320-28;FaxNo.:+91-22-25960329;Email:plethicoipo@intimespectrum.com



Place: Indore
Date: May 02, 2006

For Plethico Pharmaceuticals Limited
Sd/-
Shashikant Patel
Chairman & Managing Director

THE LEVELOF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OFTHE EQUITY SHARE ON LISTING OR THE BUSINESS PROSPECTS OF PLETHICO PHARMACEUTICALS LIMITED.

Close